M Perrot-Applanat
Overview
Explore the profile of M Perrot-Applanat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phrakonkham P, Brouland J, Saad H, Berges R, Pimpie C, Pocard M, et al.
Reprod Toxicol
. 2014 Jun;
54:101-9.
PMID: 24915137
Endocrine disruptors may play substantial roles in the high incidence of breast cancer. We previously described how early exposure to the mixture of phytoestrogen genistein (G) and the anti-androgen vinclozolin...
2.
Saad H, Toullec A, Vacher S, Pocard M, Bieche I, Perrot-Applanat M
J Endocrinol
. 2012 Nov;
216(2):245-63.
PMID: 23160963
Exposure to low doses of environmental estrogens such as bisphenol A and genistein (G) alters mammary gland development. The effects of environmental anti-androgens, such as the fungicide vinclozolin (V), on...
3.
Saad H, Meduri G, Phrakonkham P, Berges R, Vacher S, Djallali M, et al.
Reprod Toxicol
. 2011 May;
32(1):15-25.
PMID: 21539910
The impact of early exposure to endocrine disruptor mixtures on mammary gland development is poorly known. Here, we identify the effects of a conception to weaning exposure of rats to...
4.
Herve M, Meduri G, Petit F, Domet T, Lazennec G, Mourah S, et al.
J Endocrinol
. 2006 Jan;
188(1):91-9.
PMID: 16394178
The induction of vascular endothelial growth factor (VEGF) expression by 17beta-estradiol (E(2)) in many target cells, including epithelial cells, fibroblasts and smooth muscle cells, suggests a role for this hormone...
5.
Bausero P, Cavaille F, Meduri G, Freitas S, Perrot-Applanat M
Angiogenesis
. 2003 Oct;
2(2):167-82.
PMID: 14517472
Vascular endothelial growth factor (VEGF) is an endothelium-specific growth factor with potent angiogenic activity and a stimulator of microvascular permeability. Because endometrial cyclic development is associated with vascular growth, we...
6.
Benassayag C, Perrot-Applanat M, Ferre F
J Chromatogr B Analyt Technol Biomed Life Sci
. 2002 Sep;
777(1-2):233-48.
PMID: 12270216
Although numerous reports exist on the potential beneficial role of nutritional phytoestrogens in human health, their molecular mechanism in target cells is still not completely understood. Phytoestrogens promote estrogen and...
7.
Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M
J Clin Endocrinol Metab
. 2001 Mar;
86(3):1379-86.
PMID: 11238535
The recent discovery of a new isoform of estrogen receptor (ER) beta has prompted the reexamination of estrogen action on target organs. Here, we describe the endometrial expression of human...
8.
Perrot-Applanat M, Ancelin M, Meduri G, Bausero P
Steroids
. 2000 Dec;
65(10-11):599-603.
PMID: 11108865
Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is fundamental for human endometrial development and differentiation, which are necessary for implantation. This vascular process is supposed to be...
9.
Bausero P, Mazucatelli J, Bloy C, Perrot-Applanat M
Am J Physiol Heart Circ Physiol
. 2000 Oct;
279(5):H2033-42.
PMID: 11045935
Vascular endothelial growth factor (VEGF) promotes neovascularization, microvascular permeability, and endothelial proliferation. We described previously VEGF mRNA and protein induction by estradiol (E2) in human endometrial fibroblasts. We report here...
10.
Meduri G, Bausero P, Perrot-Applanat M
Biol Reprod
. 2000 Jan;
62(2):439-47.
PMID: 10642585
Angiogenesis is fundamental for human endometrial development and differentiation necessary for implantation. These vascular changes are thought to be mediated by the vascular endothelial growth factor (VEGF), whose specific receptors...